This March was supposed to mark the triumphant return of Brazil's prodigal son, yet Neymar's trend of March absences ...

How do we rate a Device? Rating a smartphone is a tedious process and a lot of parameters have to be considered before judging the overall performance of the device such as display, camera ...

Q4 2024 Earnings Call Transcript March 20, 2025 Monte Rosa Therapeutics, Inc. beats earnings expectations. Reported EPS is $0 ...

It looks like SoftBank's Vision Fund 2 is coming back strong. In the last nearly two quarters, the fund has participated in ...

Reuters reported that President Trump’s tariffs have impacted the broader stock markets, weighing on investors’ sentiments, ...

AstraZeneca will acquire EsoBiotec for a total consideration of up to $1billion, on a cash and debt free basis. This will ...

Reports cash equivalents, and marketable securities as of December 31, were $152.5M compared to $205.2M as of December 31, 2023. The decrease ...

The rapid development of gene therapy options for treating neuromuscular diseases has created new therapeutic options but ...

Cantor Fitzgerald issued their FY2025 EPS estimates for Intellia Therapeutics in a research report issued on Monday, March 17th. Cantor Fitzgerald analyst R. Bienkowski anticipates that the company ...

GenScript Biotech Corp., a global biotechnology leader in life science, biologics manufacturing, synthetic biology, and cell therapies, announced an exciting investment in gene editing technology.

Xiaomi was in a net cash position of CNY 73 billion at end-December 2024. The company indicated it will continue to invest in largely minority stakes in companies that can help build its Internet of ...